Trials / Completed
CompletedNCT05184387
A Prospective Epidemiological Cohort Study Evaluating Occurrences of Influenza-like Illness.
A Prospective Epidemiological Cohort Study Evaluating Occurrences of Influenza-like Illness in an Urban and Suburban Population of Healthy Subjects Aged 18-55 Years, Not Vaccinated Against Influenza.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 66 (actual)
- Sponsor
- Osivax · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This Prospective epidemiological cohort study is being conducted in order to generate epidemiological data in support of Osivax's clinical development of a broad spectrum influenza vaccine based upon the internal influenza nucleoprotein (NP) as a target for immune response.
Detailed description
The present study is being conducted in order to generate epidemiological data in support of Osivax's clinical development of a broad spectrum influenza vaccine based upon the internal influenza nucleoprotein (NP) as a target for immune response.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood samples | Collection of blood samples and completion of an electronic Diary (eDiary) |
Timeline
- Start date
- 2021-12-01
- Primary completion
- 2022-07-12
- Completion
- 2022-07-12
- First posted
- 2022-01-11
- Last updated
- 2022-07-19
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT05184387. Inclusion in this directory is not an endorsement.